Table 3 Frequency of achievement of composite endpoints among study groups
BMI <25 kg/m2 | BMI 25–<30 kg/m2 | BMI 30–<35 kg/m2 | BMI ≥35 kg/m2 | p value | |
|---|---|---|---|---|---|
HbA1c <7 % and no symptomatic hypoglycemia, n (%) | 26 (19.6) | 58 (26.1) | 49 (29.5) | 42 (29.8) | 0.18 |
HbA1c <7 % and no severe hypoglycemia, n (%) | 47 (35.3) | 76 (34.2) | 69 (41.6) | 65 (46.1) | 0.10 |
HbA1c <7 % and no weight gain, n (%) | 31 (23.3) | 54 (24.3) | 48 (28.9) | 49 (34.8) | 0.10 |
HbA1c <7 %, no symptomatic hypoglycemia, and no weight gain, n (%) | 16 (12.0) | 42 (18.9) | 36 (21.7) | 29 (20.6) | 0.16 |
HbA1c <7 %, no severe hypoglycemia, and no weight gain, n, (%) | 31 (23.3) | 54 (24.3) | 48 (28.9) | 48 (34.0) | 0.14 |